Menu
Back to User profile » Dr Nicola Squillace
Papers published by Dr Nicola Squillace:
HIV and SARS-CoV-2 Co-Infection: What are the Risks?
Squillace N, Ricci E, Colella E, Bonfanti P
Infection and Drug Resistance 2021, 14:3991-4014
Published Date: 28 September 2021
The Role for Tocilizumab in COVID-19 Patients: Reflections on Monza Cohort Data
Capici S, Sala L, Galimberti S, Valsecchi MG, Squillace N, Gustinetti G, Cazzaniga ME, Bonfanti P
Infection and Drug Resistance 2021, 14:1389-1392
Published Date: 13 April 2021
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
Squillace N, Ricci E, Menzaghi B, De Socio GV, Passerini S, Martinelli C, Mameli MS, Maggi P, Falasca K, Cordier L, Celesia BM, Salomoni E, Di Biagio A, Pellicanò GF, Bonfanti P
Drug Design, Development and Therapy 2020, 14:5515-5520
Published Date: 15 December 2020
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort
Bonfanti P, De Vito A, Ricci E, Menzaghi B, Orofino G, Squillace N, Molteni C, De Socio GV, Salomoni E, Celesia BM, Dentone C, Colombo V, Madeddu G
Infection and Drug Resistance 2020, 13:2291-2300
Published Date: 14 July 2020
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project
Bagella P, Squillace N, Ricci E, Gulminetti R, De Socio GV, Taramasso L, Pellicanò G, Menzaghi B, Celesia BM, Dentone C, Orofino G, Bonfanti P, Madeddu G
Infection and Drug Resistance 2019, 12:1385-1391
Published Date: 23 May 2019
Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era
Squillace N, Bozzi G, Colella E, Gori A, Bandera A
Drug Design, Development and Therapy 2018, 12:3635-3643
Published Date: 29 October 2018
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project
Bagella P, De Socio GVL, Ricci E, Menzaghi B, Martinelli C, Squillace N, Maggi P, Orofino G, Calza L, Carenzi L, Celesia BM, Penco G, Di Biagio A, Valsecchi L, Vichi F, Colombo V, Parruti G, Dentone C, Falasca K, Bonfanti P, Madeddu G
Infection and Drug Resistance 2018, 11:615-623
Published Date: 26 April 2018